Home › Bind and Amgen in $180M cancer drug research deal
 

Keywords :   


Bind and Amgen in $180M cancer drug research deal

2013-01-09 13:01:40| Biotech - Topix.net

Drug developer Bind Biosciences said Tuesday that it will study potential cancer treatments with biotechnology company Amgen Inc.

Tags: research deal drug cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11MSX2
24.11CITY 1-13
24.11 Loveyoursself Soul DVD
24.11B787-8 1/400
24.11GIANT CONTEND SL1105
24.11HappySanrio characters Halloween
24.11
24.11emmi
More »